Vans Medicare & Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 1.00 M
as on 08-12-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit 94.26%
(FY 2020)
- Ebitda 87.21%
(FY 2020)
- Net Worth -0.75%
(FY 2020)
- Total Assets -0.59%
(FY 2020)
About Vans Medicare & Biotechnology
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arun Kedia and Pawan Losalka serve as directors at the Company.
- CIN/LLPIN
U33110DL2008PTC179764
- Company No.
179764
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2008
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vans Medicare & Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kedia  | Director | 19-Jun-2008 | Current |
| Pawan Losalka | Director | 07-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Vans Medicare & Biotechnology.
Vans Medicare & Biotechnology Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.26% increase in profit. The company's net worth dipped by a decrease of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vans Medicare & Biotechnology?
In 2019, Vans Medicare & Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rishi Kunj Constructions Company Pvt. Ltd.Active 35 years 4 months
Arun Kedia and Pawan Losalka are mutual person
- Indo American Developers Private LimitedActive 24 years 10 months
Arun Kedia and Pawan Losalka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vans Medicare & Biotechnology?
Unlock and access historical data on people associated with Vans Medicare & Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vans Medicare & Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vans Medicare & Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
